课题基金 / 基金详情

Pragmatic, multicentre, cluster, cohort randomised controlled treat-to-target trial for treatment of small intestinal bacterial overgrowth in systemic sclerosis

Pragmatic, multicentre, cluster, cohort randomised controlled treat-to-target trial for treatment of small intestinal bacterial overgrowth in systemic sclerosis
用于治疗系统性硬化症小肠细菌过度生长的务实、多中心、集群、队列随机对照治疗目标试验
批准号：
350360
负责人：
Baron Murray
金额：
$14.2万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-05-01 至 2019-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=350360&lang=en
关键词：
Antibiotics Fibrosis Gastrointestinal Disease Pragmatic Trial Prokinetic Drugs Small Intestinal Bacterial Overgrowth Systemic Sclerosis Treatment

项目摘要

项目成果

Baron Murray的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Systemic Sclerosis (SSc), or scleroderma, is a rare, multi-system disorder of connective tissue disease characterized by thickening and fibrosis of the skin and involvement of internal organs. The gastrointestinal tract (GIT) is the most commonly involved
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early Immune System Events Leading to Systemic Sclerosis
Canadian Scleroderma Research Group Meeting: Training and standardization of biospecimen collection and biobanking protocols for Scleroderma Research in Canada
Canada Netherlands Systemic Sclerosis Collaborative Research Project
Meeting of the Canadian Consortium of Rheumatology Cohorts (CANCoRC)
海外基金